The relevance of reproducibility for drug development: an introduction – EATRIS Webinar series (1/6)Join event
|Date & Time||November 8, 2019, 15.00-16.00 CET|
- Leonard Freedman (Chief Scientific Officer, Frederick National Laboratory for Cancer Research)
- Andreas Scherer (Research Coordinator / Business development, Institute for Molecular Medicine Finland (FIMM))
The drug development field is facing high irreproducibility rates. To address and discuss reproducibility issues and improvement of measures ensuring more robust data quality along the drug development pipeline, EATRIS, the European Infrastructure for Translational Medicine, is running this webinar series. During this first webinar, we will briefly introduce EATRIS, along with the EATRIS Quality Initiative, and get a thorough introduction and analysis of the current reproducibility issues by Leonard Freedman PhD, Chief Scientific Officer at Frederick National Laboratory for Cancer Research. An interactive Q&A session will conclude this 60-minute-webinar.
Reproducibility is a foundational element of the scientific method, a benchmark upon which the reliability of an experiment can be tested. However, the field is facing alarmingly high irreproducibility rates as illustrated in various industry publications, with reports ranging from 50% to 80% of published results not being reproducible. It has been estimated that in the US alone, $28B in funding is spent on preclinical research that is not reproducible. This estimation does not even consider the impact on delaying translational research and causing high failure rates observed for the development of new treatments.
In this context, EATRIS will run a series of webinars this fall, looking at reproducibility issues experienced during specific phases of the drug development pipeline (screening, preclinical models, biomarker development & analytical platforms, clinical validation). The aim is to bring best practices together and to discuss solutions designed to tackle the identified bottlenecks. The first one is scheduled on November 8 between 15.00 -16.00.
You will have the chance to get the latest updates from experts in the field as well as participate in a Q&A session at the end of the lecture. Please note that you will have the opportunity to watch again later as all webinars will be recorded.